Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma

André Goy; Mark Berger; Peggy Ford; Tatyana Feldman; Anthony Mato; Colleen Bejot; Henry C. Fung

doi:10.3109/10428194.2014.900760

Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma

André Goy
, Mark Berger
, Peggy Ford
, Tatyana Feldman
, Anthony Mato
, Colleen Bejot
, Henry C. Fung

Rutgers - The State University of New Jersey, Newark
Deciphera Pharmaceuticals, LLC.
Temple University

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English
Pages (from-to)	2932-2934
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	55
Issue number	12
DOIs	https://doi.org/10.3109/10428194.2014.900760
State	Published - Dec 1 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antibodies, Monoclonal, Murine-Derived/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/adverse effects
Drug Administration Schedule
Humans
Indoles
Lymphoma, Follicular/drug therapy
Pyrroles/administration & dosage
Rituximab
Treatment Outcome

Access to Document

10.3109/10428194.2014.900760

Cite this

@article{7c91f40533fb4f6a95bb8d1f6b30cd96,

title = "Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma",

keywords = "Antibodies, Monoclonal, Murine-Derived/administration \& dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Drug Administration Schedule, Humans, Indoles, Lymphoma, Follicular/drug therapy, Pyrroles/administration \& dosage, Rituximab, Treatment Outcome",

author = "Andr{\'e} Goy and Mark Berger and Peggy Ford and Tatyana Feldman and Anthony Mato and Colleen Bejot and Fung, \{Henry C.\}",

year = "2014",

month = dec,

day = "1",

doi = "10.3109/10428194.2014.900760",

language = "English",

volume = "55",

pages = "2932--2934",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

number = "12",

}

TY - JOUR

T1 - Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma

AU - Goy, André

AU - Berger, Mark

AU - Ford, Peggy

AU - Feldman, Tatyana

AU - Mato, Anthony

AU - Bejot, Colleen

AU - Fung, Henry C.

PY - 2014/12/1

Y1 - 2014/12/1

KW - Antibodies, Monoclonal, Murine-Derived/administration & dosage

KW - Antineoplastic Combined Chemotherapy Protocols/adverse effects

KW - Drug Administration Schedule

KW - Humans

KW - Indoles

KW - Lymphoma, Follicular/drug therapy

KW - Pyrroles/administration & dosage

KW - Rituximab

KW - Treatment Outcome

UR - https://www.scopus.com/pages/publications/84919461960

U2 - 10.3109/10428194.2014.900760

DO - 10.3109/10428194.2014.900760

M3 - Letter

C2 - 24611663

AN - SCOPUS:84919461960

SN - 1042-8194

VL - 55

SP - 2932

EP - 2934

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 12

ER -

Sequential single-agent obatoclax mesylate (GX15-070MS) followed by combination with rituximab in patients with previously untreated follicular lymphoma

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this